Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $2.9250 (0.52%) ($2.9250 - $2.9250) on Mon. Mar. 7, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.84% (three month average) | RSI | 48 | Latest Price | $2.9250(0.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1% a day on average for past five trading days. | Weekly Trend | CGEN advances 0.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(86%) SKYY(84%) IWO(83%) QQQ(82%) ARKG(80%) | Factors Impacting CGEN price | CGEN will decline at least -1.92% in a week (0% probabilities). VIXM(-83%) VXX(-57%) UUP(-34%) EDOC(-32%) UNG(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.92% (StdDev 3.84%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $3.04 | 5 Day Moving Average | $3.04(-3.78%) | 10 Day Moving Average | $2.98(-1.85%) | 20 Day Moving Average | $3.04(-3.78%) | To recent high | -37.8% | To recent low | 6.4% | Market Cap | $242m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |